Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prevention of Further Absorption of Poison01:14

Prevention of Further Absorption of Poison

In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents01:24

Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents

In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents01:20

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents

The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Subcellular chemical mapping using correlated cryogenic electron and mass spectrometry imaging.

Nature methods·2026
Same author

Functional characterisation of tumour suppressor PDCD4 reveals previously undisclosed role in the control of cell adhesion.

Nucleic acids research·2026
Same author

Inhibiting translation elongation by reducing eIF5A activity induces feedback inhibition of initiation, limiting tumour cell proliferation.

Nature communications·2025
Same author

Industrial and agricultural chemicals exhibit antimicrobial activity against human gut bacteria in vitro.

Nature microbiology·2025
Same author

Community-ecosystem interactions control plant biodiversity change before and after mangrove restoration.

Ecological applications : a publication of the Ecological Society of America·2025
Same author

Strategic Litigation, Public Health, and the Decriminalization of Same-Sex Sexual Intimacy: Lessons From Legal Challenges Across Former British Colonies.

American journal of public health·2025
Same journal

Use of comprehensive geriatric assessment among oncologists in Uruguay: perceptions, practices and barriers.

Ecancermedicalscience·2026
Same journal

Age and sex-based differences in therapy preferences among patients with cancer: evidence from a novel therapy preference scale.

Ecancermedicalscience·2026
Same journal

Prospective evaluation of locoregional control in oral cavity squamous cell carcinoma with lower or mid infratemporal fossa involvement treated with surgery and adjuvant concurrent chemoradiotherapy.

Ecancermedicalscience·2026
Same journal

Trends in incidence and mortality of acute and chronic leukaemias in Brazil: challenges and advances over three decades.

Ecancermedicalscience·2026
Same journal

A scoping review on pathways/models/frameworks for palliative care provision for cancer patients while admitted at hospitals within sub-Saharan Africa.

Ecancermedicalscience·2026
Same journal

Cost-effectiveness and budget impact of breast cancer genetic profiling in Egypt.

Ecancermedicalscience·2026
See all related articles

Related Experiment Video

Updated: May 12, 2026

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
13:38

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on: January 18, 2017

Aspirin for the next generation.

Nick Henderson1, Tom Smith

  • 1Aspirin Foundation, PO Box 223, Haslemere GU27 3ZJ, UK.

Ecancermedicalscience
|April 17, 2013
PubMed
Summary
This summary is machine-generated.

Aspirin, initially for pain and fever, now impacts platelet activity to prevent heart attacks and strokes. Recent research explores its potential in cancer, diabetes, and dementia.

Keywords:
Hughes syndromeaspirincancerdementiadiabetes

More Related Videos

Generation of hiPSC-Derived Intestinal Organoids for Developmental and Disease Modelling Applications
06:34

Generation of hiPSC-Derived Intestinal Organoids for Developmental and Disease Modelling Applications

Published on: March 8, 2024

Generation of 3D Tumor Spheroids for Drug Evaluation Studies
10:33

Generation of 3D Tumor Spheroids for Drug Evaluation Studies

Published on: February 24, 2023

Related Experiment Videos

Last Updated: May 12, 2026

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
13:38

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on: January 18, 2017

Generation of hiPSC-Derived Intestinal Organoids for Developmental and Disease Modelling Applications
06:34

Generation of hiPSC-Derived Intestinal Organoids for Developmental and Disease Modelling Applications

Published on: March 8, 2024

Generation of 3D Tumor Spheroids for Drug Evaluation Studies
10:33

Generation of 3D Tumor Spheroids for Drug Evaluation Studies

Published on: February 24, 2023

Area of Science:

  • Pharmacology and Vascular Medicine
  • Oncology
  • Neurology
  • Endocrinology

Background:

  • Aspirin was initially recognized for its analgesic and antipyretic properties.
  • Its anti-inflammatory effects were later identified, leading to its use in vascular disorders.
  • Established in 1974, aspirin's role in altering platelet activity became crucial for managing myocardial infarction and cerebrovascular disease.

Purpose of the Study:

  • To review the established role of aspirin in vascular disease prevention.
  • To explore emerging research into aspirin's potential applications beyond cardiovascular health.
  • To highlight new therapeutic areas including cancer, diabetes, dementia, and gynaecology.

Main Methods:

  • Review of historical data on aspirin's pharmacological effects.
  • Analysis of findings presented at the 25th International Scientific Meeting on aspirin.
  • Synthesis of current research trends in aspirin's broader therapeutic applications.

Main Results:

  • Aspirin is a standard treatment for preventing vascular disorders by influencing platelet activity.
  • The 25th International Scientific Meeting showcased novel research directions for aspirin.
  • Emerging evidence suggests potential benefits of aspirin in oncology, diabetes, dementia, and gynaecology.

Conclusions:

  • Aspirin's therapeutic applications have expanded significantly beyond its initial uses.
  • Ongoing research continues to uncover new potential benefits of aspirin in diverse medical fields.
  • Aspirin remains a critical drug with evolving roles in disease prevention and treatment.